Tiansheng Pharmaceutical Group Co., Ltd.
SZSE:002872.SZ
4.97 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 192.712 | 278.25 | 338.676 | 291.734 | 318.163 | 327.282 | 606.27 | 418.964 | 200.999 | 166.652 | 174.534 | 136.376 |
| Short Term Investments
| -87.67 | -68.298 | 82 | -52.693 | -55.161 | 8.958 | 100 | -37.041 | -41.555 | -19.604 | -8.815 | -5.701 |
| Cash and Short Term Investments
| 192.712 | 278.25 | 420.676 | 291.734 | 318.163 | 327.282 | 606.27 | 418.964 | 200.999 | 166.652 | 174.534 | 136.376 |
| Net Receivables
| 357.648 | 401.346 | 362.397 | 660.748 | 954.442 | 1,042.413 | 895.732 | 653.012 | 614.323 | 523.208 | 513.38 | 348.855 |
| Inventory
| 136.219 | 130.873 | 124.583 | 288.58 | 295.645 | 469.972 | 518.823 | 408.242 | 461.385 | 448.813 | 424.492 | 257.921 |
| Other Current Assets
| 4.462 | 5.614 | 12.55 | 69.867 | 75.907 | 36.666 | 114.887 | -68.202 | -17.768 | -24.159 | -6.365 | -3.249 |
| Total Current Assets
| 691.042 | 816.084 | 920.206 | 1,310.928 | 1,644.156 | 1,876.333 | 2,135.712 | 1,412.017 | 1,258.939 | 1,114.515 | 1,106.042 | 739.903 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,575.136 | 1,607.362 | 1,631.032 | 1,752.251 | 2,142.379 | 2,122.662 | 2,028.162 | 1,382.438 | 1,064.488 | 849.633 | 677.584 | 656.237 |
| Goodwill
| 0 | 0 | 0 | 3.638 | 8.787 | 18.458 | 14.346 | 2.68 | 2.68 | 2.68 | 1.273 | 1.273 |
| Intangible Assets
| 311.775 | 319.496 | 327.142 | 368.717 | 427.892 | 435.488 | 418.224 | 395.484 | 369.629 | 307.157 | 279.433 | 282.868 |
| Goodwill and Intangible Assets
| 311.775 | 319.496 | 327.142 | 372.356 | 436.678 | 453.946 | 432.57 | 398.164 | 372.309 | 309.837 | 280.706 | 284.141 |
| Long Term Investments
| 140.369 | 120.754 | -31.996 | 66.224 | 66.431 | 0 | 12.685 | 46.233 | 50.663 | 21.89 | 10.59 | 22.449 |
| Tax Assets
| 68.068 | 64.147 | 69.151 | 97.811 | 53.442 | 40.525 | 39.272 | 29.794 | 24.779 | 26.534 | 14.746 | 11.743 |
| Other Non-Current Assets
| 24.517 | 41.984 | 204.491 | 46.369 | 48.375 | 180.35 | 298.087 | 123.33 | 94.935 | 172.717 | 69.253 | 29.46 |
| Total Non-Current Assets
| 2,119.865 | 2,153.744 | 2,199.819 | 2,335.011 | 2,747.305 | 2,797.482 | 2,810.777 | 1,979.959 | 1,607.174 | 1,380.611 | 1,052.88 | 1,004.031 |
| Total Assets
| 2,810.906 | 2,969.827 | 3,120.025 | 3,645.94 | 4,391.461 | 4,673.815 | 4,946.489 | 3,391.976 | 2,866.112 | 2,495.126 | 2,158.922 | 1,743.934 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 77.343 | 55.305 | 126.448 | 297.177 | 294.18 | 331.735 | 401.977 | 499.342 | 375.767 | 342.479 | 400.202 | 283.026 |
| Short Term Debt
| 200.066 | 236.349 | 185.847 | 365.35 | 610.7 | 674.7 | 816.48 | 656.1 | 571.9 | 420.06 | 352.43 | 229.873 |
| Tax Payables
| 3.567 | 21.023 | 7.193 | 6.352 | 18.335 | 31.734 | 43.914 | 40.106 | 27.244 | 26.887 | 27.697 | 15.863 |
| Deferred Revenue
| 162.008 | 47.707 | 141.663 | 243.135 | 278.897 | 0 | 34.259 | 96.799 | 70.147 | 60.097 | 60.643 | 99.391 |
| Other Current Liabilities
| 15.131 | 216.033 | 18.595 | 3.999 | 16.762 | 229.494 | 228.409 | 16.171 | 31.936 | 27.381 | 11.07 | 7.903 |
| Total Current Liabilities
| 454.549 | 555.395 | 472.552 | 909.661 | 1,200.539 | 1,235.929 | 1,481.125 | 1,268.412 | 1,049.75 | 850.017 | 824.345 | 620.193 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 62.257 | 31.238 | 165.019 | 129.09 | 14 | 14 | 26.75 | 10 | 15 | 57.4 | 105.13 | 29.9 |
| Deferred Revenue Non-Current
| 127.794 | 126.338 | 131.463 | 150.966 | 164.945 | 186.788 | 189.382 | 193.392 | 172.203 | 156.539 | 151.589 | 142.02 |
| Deferred Tax Liabilities Non-Current
| 4.468 | 2.015 | 2.807 | 1.089 | 1.004 | 0.999 | 0.271 | 0.222 | 0.21 | 0.199 | 0.122 | 0.165 |
| Other Non-Current Liabilities
| 66.178 | 67.25 | 68.947 | 65.42 | 56.75 | 54.28 | 59.67 | 61 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 260.698 | 226.84 | 368.236 | 346.565 | 236.699 | 256.067 | 276.073 | 264.614 | 187.413 | 214.138 | 256.841 | 172.086 |
| Total Liabilities
| 715.246 | 782.235 | 840.788 | 1,256.226 | 1,437.238 | 1,491.996 | 1,757.199 | 1,533.027 | 1,237.162 | 1,064.155 | 1,081.186 | 792.278 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 318 | 318 | 318 | 318 | 318 | 318 | 212 | 159 | 159 | 159 | 141.12 | 141.12 |
| Retained Earnings
| 226.405 | 319.479 | 410.042 | 477.847 | 970.07 | 1,234.292 | 1,277.683 | 1,045.701 | 834.3 | 657.62 | 507.047 | 393.9 |
| Accumulated Other Comprehensive Income/Loss
| 146.299 | 144.519 | 144.61 | 143.733 | 148.523 | 100.05 | 101.472 | 600.702 | 587.452 | 1.549 | 0.984 | 0 |
| Other Total Stockholders Equity
| 1,400.779 | 1,400.779 | 1,400.779 | 1,400.779 | 1,460.676 | 1,461.937 | 1,541.941 | 0 | 0 | 570.425 | 395.504 | 388.234 |
| Total Shareholders Equity
| 2,091.483 | 2,182.777 | 2,273.432 | 2,340.36 | 2,897.27 | 3,114.279 | 3,133.096 | 1,805.403 | 1,580.751 | 1,388.594 | 1,044.655 | 923.253 |
| Total Equity
| 2,095.66 | 2,187.593 | 2,279.237 | 2,389.714 | 2,954.223 | 3,181.819 | 3,189.29 | 1,858.949 | 1,628.95 | 1,430.972 | 1,077.735 | 951.656 |
| Total Liabilities & Shareholders Equity
| 2,810.906 | 2,969.827 | 3,120.025 | 3,645.94 | 4,391.461 | 4,673.815 | 4,946.489 | 3,391.976 | 2,866.112 | 2,495.126 | 2,158.922 | 1,743.934 |